Logo (WIPO, 05.07.2018)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke wurde als Bildmarke am 05.07.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Natürliche Phänomene #Andere geometrische Figuren, undefinierbare Designs #Lichtquellen, Strahlen, Lichtschächte #Andere Naturphänomene, die nicht in anderen Abteilungen oder Kategorien klassifiziert sind, Boden, Nordlicht (Aurora borealis)
| Markenform | Bildmarke |
| Aktenzeichen | 1427893 |
| Länder | 
|
| Basismarke |
Nr. 87748391,
09. Januar 2018
|
| Anmeldedatum | 05. Juli 2018 |
| Ablaufdatum | 05. Juli 2028 |
Markeninhaber
5959 Horton Street,
Suite 300
US
Suite 300
US
Markenvertreter
7751 CARONDELET AVE, #405
ST LOUIS MO 63105
US
Waren und Dienstleistungen
05
Pharmaceutical preparations for the treatment of cancer;
anti-cancer preparations; vaccines; vaccine preparations
09
Next-generation sequencing (NGS) data processor;
bioinformatics data processor; downloadable computer
software for genome analysis, developing personal treatment
strategies for patients with diagnosed cancer, analyzing,
screening, identifying, quantifying, and interpreting data
in the field of mass spectrometry
42
Providing temporary use of on-line nondownloadable software
and applications for genome analysis, developing personal
treatment strategies for patients with diagnosed cancer;
conducting evaluations in the field of pharmaceuticals;
conducting early evaluations in the field of
pharmaceuticals; consulting services in the fields of
biotechnology and pharmaceutical research; pharmaceutical
product development and evaluation services; pharmaceutical
research and development; providing medical and scientific
research information in the field of pharmaceuticals and
clinical trials; research and development of pharmaceuticals
for the treatment of cancer; research and development of
vaccines and medicines; technical research in the field of
pharmaceutical studies; development of platform technology,
namely, cancer immunotherapy platforms for manufacturing
therapeutics; conducting clinical trials for others in the
field of pharmaceuticals for the treatment and prevention of
cancer; consulting services for others in the field of
design, planning, and implementation of clinical trials;
collection of specific molecular and genomic data for
analytical and clinical purposes, for the treatment of
cancer and other diseases and disorders and for individuals'
responses to drug treatments; scientific research services,
namely, collection of specific molecular and genomic data
for analytical and clinical purposes, for the treatment of
cancer and other diseases and disorders and for individuals'
responses to drug treatments; providing scientific advice in
the fields of cancer biology, cancer treatment,
pharmaceutical side effects, genomics, cancer medicine and
translational medicine; providing scientific analysis in the
field of next generation sequencing (NGS), namely, the
analysis and interpretation of genomic data obtained from
cancer patients; providing an online, non-downloadable
computer software platform for purposes of storing and
providing information about an individual's cancer profile
and genomic changes to enable physicians and healthcare
professionals to optimize treatment in clinical practice
44
Healthcare
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 13. Mai 2022 | 2022/26 Gaz | US | RAW: Partial Ceasing Effect |
| 26. April 2022 | 2022/18 Gaz | PH | Ablehnung |
| 05. April 2022 | 2022/17 Gaz | PH | RAW: Total Invalidation |
| 04. Januar 2022 | 2022/1 Gaz | Korrektur | |
| 20. November 2020 | 2020/49 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 02. April 2020 | 2020/15 Gaz | TH | Ablehnung |
| 30. März 2020 | 2020/14 Gaz | ID | Ablehnung |
| 27. Februar 2020 | 2020/10 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. November 2019 | 2019/45 Gaz | CO | Ablehnung |
| 10. Oktober 2019 | 2019/41 Gaz | JP | Ablehnung |
| 27. September 2019 | 2019/40 Gaz | NO | Ablehnung |
| 23. September 2019 | 2019/39 Gaz | KR | Ablehnung |
| 09. September 2019 | 2019/37 Gaz | CH | Ablehnung |
| 08. August 2019 | 2019/38 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. August 2019 | 2019/32 Gaz | IL | Ablehnung |
| 04. Juli 2019 | 2019/27 Gaz | MX | Ablehnung |
| 10. Juni 2019 | 2019/24 Gaz | IN | Ablehnung |
| 05. Juni 2019 | 2019/24 Gaz | AU | Ablehnung |
| 23. April 2019 | 2019/18 Gaz | RU | Ablehnung |
| 19. März 2019 | 2019/12 Gaz | EM | Ablehnung |
| 18. März 2019 | 2019/12 Gaz | TR | Ablehnung |
| 12. März 2019 | 2019/11 Gaz | CN | Ablehnung |
| 01. März 2019 | 2019/9 Gaz | NZ | Ablehnung |
| 08. Februar 2019 | 2019/7 Gaz | SG | Ablehnung |
| 23. Oktober 2018 | 2018/43 Gaz | PH | Ablehnung |
| 05. Juli 2018 | 2018/39 Gaz | US | Eintragung |
ID: 141427893